SEARCH

SEARCH BY CITATION

References

  • Albanese CJ, Johnson G, Watanabe N, Eklund D, Vu D and Pestell RG (1995) Transforming p21 ras mutants and ets2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem, 270, 2358923597.
  • Barker N, Huls G, Korinek V and Clevers H (1999) Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol, 154, 2935.
  • Barker N, Morin PJ and Clevers H (2000) The yin–yang of TCF/β-catenin signaling. Adv Cancer Res, 77, 124.
  • Bieche I, Khodja A, Driouch K and Lidereau R (1997) Genetic alteration mapping on chromosome 7 in primary breast cancer. Clin Cancer Res, 3, 10091016.
  • Bienz M (1998) TCF: transcriptional activator or repressor. Curr Opin Cell Biol, 10, 366372.
  • Bienz M and Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell, 103, 311320.
  • Billin AN, Thirlwell H and Ayer DE (2000) β-catenin–histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol, 20, 68826890.
  • Chan EF, Gat U, McNiff JM and Fuchs E (1999) A common human skin tumour is caused by activating mutations in β-catenin. Nature Genet, 21, 410413.
  • Chen RH, Ding WV and McCormick F (2000) Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3 β inhibition and activation of protein kinase C. J Biol Chem, 275, 1789417899.
  • Driouch K, Briffod M, Bieche I, Champeme MH and Lidereau R (1998) Location of several putative genes possibly involved in human breast cancer progression. Cancer Res, 58, 20812086.
  • Eastman Q and Grosschedl R (1999) Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol, 11, 233240.
  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, daCosta L, Morin PJ, Vogelstein B and Kinzler K (1998) Identification of c-myc as a target of the APC pathway. Science, 281, 15091512.
  • Hosokawa Y and Arnold A (1998) Mechanisms of cyclin D1 (CCN1, PRAD1) overexpression in human cancer: analysis of allele-specific expression. Genes Chromosomes Cancer, 22, 6771.
  • Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF and Waterman ML (2001) β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nature Genet, 28, 5357.
  • Hsu SC, Galceran J and Grosschedl R (1998) Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol Cell Biol, 18, 48074818.
  • Ishitani T et al. (1999) The TAK1-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature, 399, 798802.
  • Koike M, Tasaka T, Spira S, Tsuruoka N and Koeffler HP (1999) Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33–34 (D7S498, D7S505). Leuk Res, 23, 307310.
  • Korinek V, Barker N, Morin PJ, van Wichen D, deWeger R, Kinzler K, Vogelstein B and Clevers H (1997) Constitutive transcriptional activation by a β-catenin–Tcf complex in APC−/− colon carcinoma. Science, 275, 17841787.
  • Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ and Clevers H (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet, 19, 379383.
  • Lavender P, Vandel L, Bannister AJ and Kouzarides T (1997) The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene, 14, 27212728.
  • Lemercier C, Duncliffe K, Boibessot I, Zhang H, Verdel A, Angelov D and Khochbin S (2000) Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol Cell Biol, 20, 66276637.
  • Li Y, Hively WP and Varmus HE (2000) Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene, 19, 10021009.
  • Liang H, Fairman J, Claxton DF, Nowell PC, Green ED and Nagarajan L (1998) Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA, 95, 37813785.
  • Lin KM, Zhao WG, Bhatnagar J, Zhao WD, Lu JP, Simko S, Schueneman A and Austin GE (2001) Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity. Leukemia, 15, 601612.
  • Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG and Hung MC (2000) β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA, 97, 42624266.
  • Love JJ, Li X, Case DA, Giese K, Grosschedl R and Wright PE (1995) Structural basis for DNA bending by the architectural transcription factor Lef-1. Nature, 376, 791795.
  • Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, Thorpe CJ, Hamill DR, Matsumoto K and Bowerman B (1999) MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature, 399, 793797.
  • Morin PJ (1999) β-catenin signaling and cancer. BioEssays, 21, 10211030.
  • Morin P, Sparks AB, Korinek V, Barker N, Clever H, Vogelstein B and Kinzler K (1997) Activation of β-catenin–TCF signalling in colon cancer by mutations in B-catenin or APC. Science, 275, 17871790.
  • Nusse R (1999) Wnt targets: repression and activation. Trends Genet, 15, 13.
  • Polakis P (2000) Wnt signaling and cancer. Genes Dev, 14, 18371851.
  • Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T and Clevers H (1999) Synergy between tumor suppressor APC and the β-catenin–Tcf4 target Tcf1. Science, 285, 19231926.
  • Satoh S et al. (2000) AXIN1 mutations in hepatocellular carcinomas and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genet, 24, 245250.
  • Shih H, Tevosian SG and Yee AS (1998) Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol Cell Biol, 18, 47324743.
  • Shih H, Berasi S, Sampson EM, Leiter AB, Paulson KE and Yee AS (2001) HMG box transcriptional repressor HPB maintains a proliferation barrier in differentiated liver tissue. Mol Cell Biol, inpress.
  • Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the B-catenin/LEF pathway. Proc Natl Acad Sci USA, 96, 55225527.
  • Tetsu O and McCormick F (1999) B-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422426.
  • Tevosian SG, Shih H, Mendelson KG, Sheppard KA, Paulson KE and Yee AS (1997) HBP-1: a new transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev, 11, 383396.
  • Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T and Varmus HE (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55, 619625.
  • Verbeek S et al. (1995) An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature, 374, 7074.
  • Waltzer L and Bienz M (1998) Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature, 395, 521525.
  • Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B and Pestell RG (1998) Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol, 18, 32123222.
  • Weinstat-Saslow D, Merino MJ, Manrow J, Lawrence RF, Bluth KD, Wittenbel JF, Simpson JF, Page DL and Steeg PS (1995) Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinoma from non-malignant lesions. Nature Med, 1, 12571259.
  • Zenklusen JC, Bieche I, Lidereau R and Conti CJ (1994) (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA, 91, 1215512158.
  • Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ (1995a) Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res, 55, 13471355.
  • Zenklusen JC, Weitzel JN, Ball HG and Conti CJ (1995b) Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene, 11, 359363.
  • Zhuma T et al. (1999) Human HMG box transcription factor HBP1: a role in hCD2 LCR function. EMBO J, 18, 63966406.
  • Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW and Varmus HE (1999) Regulation of Wnt signaling by Sox proteins: XSox17 α/β and XSox3 physically interact with β-catenin. Mol Cell, 4, 487498.